Literature DB >> 36540

Central dopamine agonistic activity and microsomal biotransformation of lisuride, lergotrile and bromocriptine.

H H Keller, M Da Prada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 36540     DOI: 10.1016/0024-3205(79)90058-4

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  7 in total

Review 1.  The motor effects of bromocriptine--a review.

Authors:  D M Jackson; O F Jenkins; S B Ross
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

2.  In vivo and in vitro dopaminergic effects of three ergoline fragments.

Authors:  J C Koons; J P Long; J G Cannon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-12       Impact factor: 3.000

3.  Evidence for an irreversible interaction of bromocryptine with central dopamine receptors.

Authors:  M J Bannon; A A Grace; B S Bunney; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

4.  The pharmacokinetics of lisuride hydrogen maleate in rat, rabbit and rhesus monkey.

Authors:  M Humpel; T Toda; N Oshino; G Pommerenke
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1981       Impact factor: 2.441

5.  Radioimmunoassay of plasma lisuride in man following intravenous and oral administration of lisuride hydrogen maleate: effect on plasma prolactin level.

Authors:  M Hümpel; B Nieuweboer; S H Hasan; H Wendt
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

6.  Effects of lisuride on body temperature of rats and rabbits: relation to microsomal biotransformation and dopaminergic receptor stimulation.

Authors:  M O Carruba; S Ricciardi; J Negreanu; M Calogero; P Mantegazza
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

7.  Microdialysis study of bromocriptine and its metabolites in rat pituitary and striatum.

Authors:  S Granveau-Renouf; D Valente; A Durocher; J M Grognet; E Ezan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Apr-Jun       Impact factor: 2.569

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.